Fortress Biotech Pref Preferred Stock Buy Hold or Sell Recommendation
| FBIOP Preferred Stock | USD 6.64 0.14 2.15% |
Assuming the 90 days horizon and your above-average risk tolerance, our recommendation regarding Fortress Biotech Pref is 'Strong Sell'. A buy or sell recommendation provided by Macroaxis is an automated analysis based on historical performance and your stated risk tolerance. It serves as guidance on whether to purchase or sell Fortress Biotech Pref within the specified time frame.
Check out Fortress Biotech Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. To learn how to invest in Fortress Preferred Stock, please use our How to Invest in Fortress Biotech guide. Note, we conduct extensive research on individual companies such as Fortress and provide practical buy, sell, or hold advice based on investors' constraints. Fortress Biotech Pref. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
Fortress |
Execute Fortress Biotech Buy or Sell Advice
The Fortress recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Fortress Biotech Pref. Macroaxis does not own or have any residual interests in Fortress Biotech Pref or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Fortress Biotech's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Weak | Details | |
Volatility | Slightly risky | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Above Average | Details | |
Economic Sensitivity | Moves totally opposite to the market | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Unavailable | Details |
Fortress Biotech Trading Alerts and Improvement Suggestions
| Fortress Biotech had very high historical volatility over the last 90 days | |
| Fortress Biotech has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 68.79 M. Net Loss for the year was (164.83 M) with loss before overhead, payroll, taxes, and interest of (85.66 M). | |
| Fortress Biotech Pref has accumulated about 248.77 M in cash with (116.54 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.31. |
Fortress Biotech Returns Distribution Density
The distribution of Fortress Biotech's historical returns is an attempt to chart the uncertainty of Fortress Biotech's future price movements. The chart of the probability distribution of Fortress Biotech daily returns describes the distribution of returns around its average expected value. We use Fortress Biotech Pref price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Fortress Biotech returns is essential to provide solid investment advice for Fortress Biotech.
| Mean Return | 0.08 | Value At Risk | -4.02 | Potential Upside | 7.27 | Standard Deviation | 3.51 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Fortress Biotech historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Fortress Biotech Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Fortress Biotech or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Fortress Biotech's price will be affected by overall preferred stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Fortress preferred stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.04 | |
β | Beta against Dow Jones | -0.99 | |
σ | Overall volatility | 3.34 | |
Ir | Information ratio | 0.05 |
Fortress Biotech Volatility Alert
Fortress Biotech Pref currently demonstrates below-average downside deviation. It has Information Ratio of 0.05 and Jensen Alpha of -0.04. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Fortress Biotech's preferred stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Fortress Biotech's preferred stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Fortress Biotech Fundamentals Vs Peers
Comparing Fortress Biotech's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Fortress Biotech's direct or indirect competition across all of the common fundamentals between Fortress Biotech and the related equities. This way, we can detect undervalued stocks with similar characteristics as Fortress Biotech or determine the preferred stocks which would be an excellent addition to an existing portfolio. Peer analysis of Fortress Biotech's fundamental indicators could also be used in its relative valuation, which is a method of valuing Fortress Biotech by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Fortress Biotech to competition |
| Fundamentals | Fortress Biotech | Peer Average |
| Return On Equity | -1.43 | -0.31 |
| Return On Asset | -0.35 | -0.14 |
| Profit Margin | (1.17) % | (1.27) % |
| Operating Margin | (2.63) % | (5.51) % |
| Current Valuation | 2.58 B | 16.62 B |
| Shares Outstanding | 56.68 M | 571.82 M |
| Shares Owned By Institutions | 1.80 % | 39.21 % |
| Number Of Shares Shorted | 245 | 4.71 M |
| Price To Sales | 1.36 X | 11.42 X |
| Revenue | 68.79 M | 9.43 B |
| Gross Profit | (85.66 M) | 27.38 B |
| EBITDA | (46.05 M) | 3.9 B |
| Net Income | (164.83 M) | 570.98 M |
| Cash And Equivalents | 248.77 M | 2.7 B |
| Cash Per Share | 2.31 X | 5.01 X |
| Total Debt | 46.56 M | 5.32 B |
| Debt To Equity | 0.81 % | 48.70 % |
| Current Ratio | 2.85 X | 2.16 X |
| Book Value Per Share | 0.57 X | 1.93 K |
| Cash Flow From Operations | (116.54 M) | 971.22 M |
| Short Ratio | 0.02 X | 4.00 X |
| Earnings Per Share | (0.86) X | 3.12 X |
| Number Of Employees | 173 | 18.84 K |
| Beta | 1.9 | -0.15 |
| Market Capitalization | 107.79 M | 19.03 B |
| Total Asset | 396.5 M | 29.47 B |
| Z Score | 1.2 | 8.72 |
| Annual Yield | 0.12 % | |
| Net Asset | 396.5 M |
Fortress Biotech Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Fortress . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Fortress Biotech Buy or Sell Advice
When is the right time to buy or sell Fortress Biotech Pref? Buying financial instruments such as Fortress Preferred Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Fortress Biotech in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Hotels Thematic Idea Now
Hotels
Hotels, inns, motels, and other companies providing lodging and hospitality services. The Hotels theme has 37 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Hotels Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Fortress Preferred Stock Analysis
When running Fortress Biotech's price analysis, check to measure Fortress Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fortress Biotech is operating at the current time. Most of Fortress Biotech's value examination focuses on studying past and present price action to predict the probability of Fortress Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fortress Biotech's price. Additionally, you may evaluate how the addition of Fortress Biotech to your portfolios can decrease your overall portfolio volatility.